shampoo)
One survey found that just 20% of companies with over 200 workers cover weight loss drugs, with only 43% of those with 5,000 employees or more doing so
In addition, semaglutide, Liraglutide, and dulaglutide have indications for reducing cardiovascular risk in patients with T2DM and established atherosclerotic cardiovascular disease [113,114,115,116,117,118]
Protocol 3: metabolic health optimization Goal: Reduce liver fat, improve insulin sensitivity, address metabolic syndrome Tirzepatide approach: Standard escalation to 10 mg Produces moderate liver fat reduction Significant HbA1c improvements (if diabetic) Meaningful but not maximal metabolic improvements Retatrutide approach: Escalation to 8-12 mg 86% of patients achieved normal liver fat at 12 mg Superior metabolic marker improvements across all measures Glucagon component directly targets hepatic lipid metabolism If metabolic health is your primary goal rather than the number on the scale, the retatrutide dosage chart offers something tirzepatide fundamentally cannot: direct glucagon-mediated liver fat reduction
Week one through four uses 0.25 mg, weeks five through eight use 0.5 mg, weeks nine through twelve use 1 mg, weeks thirteen through sixteen use 1.7 mg, and week seventeen onward uses the maximum of 2.4 mg
This information is provided for educational purposes to support informed research decisions